Evaxion - Revenue 2020-2025 | EVAX

Evaxion - revenue from 2020 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Evaxion - Annual Revenue
(Millions of US $)
2024 $3
2023 $0
2022
2021
2020
2019
Evaxion - Quarterly Revenue
(Millions of US $)
2025-09-30 $7
2025-06-30 $0
2025-03-31
2024-12-31
2024-09-30 $3
2024-06-30 $0
2023-06-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.040B $0.003B
Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.991B 41.62
Tempus AI (TEM) United States $12.261B 0.00
Doximity (DOCS) United States $7.729B 31.82
Hims & Hers Health (HIMS) United States $7.109B 57.83
IRHYTHM HLDGS (IRTC) United States $5.543B 0.00
Hinge Health (HNGE) United States $3.445B 0.00
Heartflow (HTFL) United States $3.076B 0.00
Privia Health (PRVA) United States $2.935B 183.54
Inspire Medical Systems (INSP) United States $2.803B 46.38
10x Genomics (TXG) United States $2.683B 0.00
Omnicell (OMCL) United States $2.288B 46.77
Azenta (AZTA) United States $1.835B 75.30
Enovis (ENOV) United States $1.387B 7.29
Clover Health Investments (CLOV) United States $1.354B 0.00
Schrodinger (SDGR) United States $1.287B 0.00
Butterfly Network (BFLY) United States $1.149B 0.00
Phreesia (PHR) United States $0.992B 0.00
Fulgent Genetics (FLGT) United States $0.886B 0.00
Talkspace (TALK) United States $0.634B 127.67
Standard BioTools (LAB) United States $0.608B 0.00
Claritev (CTEV) United States $0.497B 0.00
Evolent Health (EVH) United States $0.440B 0.00
Carlsmed (CARL) United States $0.360B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.349B 0.00
TruBridge (TBRG) United States $0.326B 14.99
Zepp Health (ZEPP) Netherlands $0.326B 0.00
Senseonics Holdings (SENS) United States $0.297B 0.00
CapsoVision (CV) United States $0.283B 0.00
KORU Medical Systems (KRMD) United States $0.263B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.190B 0.00
MDxHealth SA (MDXH) Belgium $0.175B 0.00
Nyxoah SA (NYXH) Belgium $0.175B 0.00
Health Catalyst (HCAT) United States $0.166B 0.00
CareCloud (CCLD) United States $0.121B 6.63
Outset Medical (OM) United States $0.095B 0.00
American Well (AMWL) United States $0.078B 0.00
HeartBeam (BEAT) United States $0.076B 0.00
Pulmonx (LUNG) United States $0.075B 0.00
EUDA Health Holdings (EUDA) Singapore $0.069B 0.00
NetraMark Holdings (AINMF) Canada $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.061B 0.00
111 (YI) China $0.049B 0.00
Precipio (PRPO) United States $0.042B 0.00
P3 Health Partners (PIII) United States $0.024B 0.00
Lunai Bioworks (LNAI) United States $0.022B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Zhongchao (ZCMD) China $0.012B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.009B 0.00
PROFUSA (PFSA) United States $0.009B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Movano (MOVE) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00